Clinical Trials Sponsored by aQua-Institut

Total 74056 results

Aqua Medical, Inc.

Active, not recruiting

Study of Duodenal Mucosal RF Vapor Ablation in Subjects With Type-2 Diabetes Mellitus (STEAM T-2DM)

Diabetes Mellitus Type 2

Chile
Aqua Medical Services (Pvt) Ltd

Completed

Spinal Decompression Therapy in Radicular Chronic Low Back Pain

Radiculopathy Lumbar

Pakistan
Aqua Medical Services (Pvt) Ltd

Completed

Decompression With ELDOA on Lumbar Disc Protrusion Patient

Lumbar Disc Herniation | Spinal Disk Injury | Protrusion

Pakistan
Aqua Medical Services (Pvt) Ltd

Withdrawn

Effects of Homocysteine in Myocardial Infarction Patients in a Tertiary Care Hospital of Pakistan

Homocystine; Metabolic Disorder

Pakistan
Aqua Medical Services (Pvt) Ltd

Completed

Compare the Effects of Decompression on Lumber Disc Protrusion Patient

Lumbar Disc Herniation

Pakistan
Aqua Medical Services (Pvt) Ltd

Completed

Effects of ELDOA in Lumber Radiculopathy

Lumbar Radiculopathy

Pakistan
Aqua Medical Services (Pvt) Ltd

Completed

kINESIOTAPING ON PATIENT'S FUNCTIONAL STATUS IN NON-SPECIFIC NECK PAIN

Neck Pain

Pakistan
Aqua Medical Services (Pvt) Ltd

Completed

Diaphragmatic Mobility In Ventilated Assisted Patients

Ventilation Therapy; Complications

Pakistan
Aqua Medical Services (Pvt) Ltd

Completed

Effect of Decompression With and Without ELDOA in Lumber Disc Protrusion Patients (ELDOA)

Lumbar Disc Herniation

Pakistan
McGuire Institute
Asua, Inc

Active, not recruiting

Development of an AI App to Improve Compliance in Periodontal Maintenance Patients

Periodontal Diseases

United States
Mir Arif Hussain

Completed

Effects of Cervical Proprioceptive Training in CMNP

Chronic Neck Pain

Pakistan
Mir Arif Hussain

Completed

Effects of Compression Mobilization in OA Patients

Osteo Arthritis Knee

Pakistan
Universitätsklinikum Hamburg-Eppendorf
Federal Joint Committee; aQua-Institut GmbH, Germany; Leibniz-Institut für Resilienzforschung... and other collaborators

Active, not recruiting

Family Health Partners in Regional Network Structures (NEST)

Disabled or Chronically Ill Children in Need of Care

Germany
MeiraGTx UK II Ltd
Syne Qua Non Limited

Completed

Long-Term Follow-Up Gene Therapy Study for Leber Congenital Amaurosis OPTIRPE65 (Retinal Dystrophy Associated With Defects in RPE65)

Eye Diseases | Retinal Diseases | Eye Diseases, Hereditary | Leber Congenital Amaurosis (LCA)

United States, United Kingdom
Felix JF Herth
DLR German Aerospace Center; University Hospital Heidelberg; Federal Joint Committee and other collaborators

Recruiting

Early Detection and Early Intervention Program in High-risk Patients to Avoid Invasive Long-term Ventilation (PRiVENT)

Weaning | Invasive Ventilation

Germany
MeiraGTx UK II Ltd
Syne Qua Non Limited; EMAS Pharma

Active, not recruiting

Long-Term Follow-Up Gene Therapy Study for Achromatopsia CNGB3 and CNGA3

Achromatopsia

United Kingdom, United States
MeiraGTx UK II Ltd
Syne Qua Non Limited; Bionical Emas

Completed

Gene Therapy for X-linked Retinitis Pigmentosa (XLRP) - Retinitis Pigmentosa GTPase Regulator (RPGR)

X-Linked Retinitis Pigmentosa

United Kingdom, United States
MeiraGTx UK II Ltd
Syne Qua Non Limited; EMAS Pharma

Completed

Gene Therapy for Achromatopsia (CNGB3) (CNGB3)

Achromatopsia

United Kingdom, United States
Blue Earth Diagnostics
Syne Qua Non Limited; Innovate UK; IND 2 Results LLC

Completed

Fluciclovine (18F) PET/CT in biochemicAL reCurrence Of Prostate caNcer (FALCON)

Cancer of the Prostate

United Kingdom
Blue Earth Diagnostics
American College of Radiology; Syne Qua Non Limited; IND 2 Results LLC

Completed

18F Fluciclovine (FACBC) PET/CT in Patients With Rising PSA After Initial Prostate Cancer Treatment (LOCATE)

Prostate Cancer

United States
Fundació Institut de Recerca de l'Hospital de la...
Sheba Medical Center; iMinds; Semmelweis University; AQuAS, Agència de Qualitat...

Completed

Study of m-RESIST, an m-Health Program for Treatment-resistant Schizophrenia (m-RESIST)

Schizophrenia

Spain, Hungary, Israel
Jules Bordet Institute
AstraZeneca; Institut Curie

Active, not recruiting

Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, +/- Oleclumab in Luminal B Breast Cancer: (Neo-CheckRay)

Luminal B

France, Belgium
The Netherlands Cancer Institute
Institut Curie

Terminated

Pre- Versus Postoperative Accelerated Partial Breast Irradiation (PAPBI-2)

Breast Cancer | Neoplasms, Breast | Cancer of the Breast

France, Netherlands, Portugal, Spain
Institut Bergonié
National Cancer Institute, France

Completed

Validation of a Screening Tool in Geriatric Oncology (ONCODAGE)

Lymphoma | Breast Cancer | Head and Neck Cancer | Colorectal Cancer | Lung Cancer | Prostate Cancer

France
Institut Bergonié

Completed

Effect of Advertisements on Treatment Compliance in Women With Breast Cancer

Breast Cancer
Institut Curie

Completed

Sunitinib as Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Transitional Cell Cancer

Bladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter

France
Institut Bergonié

Completed

MRI in Evaluating Early Response to Chemotherapy in Women Receiving Chemotherapy for Infiltrating Breast Cancer

Breast Cancer

France
Institut Bergonié

Completed

Psychological and Social Factors That May Increase the Risk of Developing Chronic Pain After Surgery in Women With Breast Cancer

Pain | Breast Cancer | Psychosocial Effects of Cancer and Its Treatment
Institut Curie

Unknown

Study of Tumor and Blood Samples From Women With Breast Cancer

Breast Cancer

France
Institut Bergonié

Unknown

Efavirenz as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer

Pancreatic Cancer

France
Institut Curie

Unknown

Radiation Therapy With or Without Temozolomide in Treating Women With Brain Metastases and Breast Cancer

Breast Cancer | Metastatic Cancer

France
Institut Curie
National Cancer Institute, France

Recruiting

LOC-R01 Study of Lenalidomide and Ibrutinib in Association With Rituximab-Methotrexate Procarbazine Vincristin (R-MPV) (LOC-R01)

Lymphoma, Large B-Cell, Diffuse | Central Nervous System Neoplasms, Primary

France
Institut Bergonié
National Cancer Institute, France

Completed

Diffuse Large B Cell Non-Hodgkin's Lymphoma in the Vulnerable/Frail Elderly. A Multicentric Randomized Phase II Trial (FRAIL-06)

Lymphoma

France
Institut Bergonié
National Cancer Institute, France

Completed

Anastrozole or Fulvestrant in Treating Postmenopausal Patients With Breast Cancer (HORGEN)

Breast Cancer

France
Institut Curie

Unknown

Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the Eye

Intraocular Melanoma

France
Institut Curie
National Cancer Institute, France

Completed

ER-One: A Double-blind Trial of Erector Spinae Block (ESP) Versus Paravertebral Block (PVB) Before Breast Cancer Surgery (ER-One)

Breast Surgery

France
Institut Bergonié
National Cancer Institute, France

Completed

A Study of Olaparib With Concomitant Radiotherapy in Locally Advanced/Unresectable Soft-tissue Sarcoma (RADIOSARP)

Soft-tissue Sarcoma

France
Institut Curie

Completed

Blood Levels of Tumor Cells in Predicting Response in Patients Receiving First-Line Chemotherapy for Stage IV Breast Cancer

Breast Cancer

France
Institut Curie

Completed

Bone Marrow and Blood Samples From Patients With Metastatic Choroid Melanoma

Intraocular Melanoma
Charite University, Berlin, Germany
Association of Statutory Health Insurance Physicians (KV Berlin); Statutory... and other collaborators

Active, not recruiting

PräVaNet - Structured, Intersectoral, Multiprofessional, Digitized Program to Optimize Cardiovascular Prevention (PräVaNet)

Arteriosclerosis | Type 2 Diabetes | Lipid Metabolism Disorders | Arterial Hypertension

Germany
Institut Bergonié
AstraZeneca; National Cancer Institute, France

Not yet recruiting

MEDI5752 in Patients With Mature Tertiary Lymphoid Structures Solid Tumors. (TAYLOR)

Advanced Solid Tumor

France
Institut Català d'Oncologia

Unknown

Study of Information Received About Fertility and Infertility in Patients Who Have Finished Treatment for Cancer

Cancer

Spain
Institut Català d'Oncologia

Unknown

Sunitinib Malate and Exemestane in Treating Postmenopausal Women With Breast Cancer

Breast Cancer

Spain
Institut Paoli-Calmettes

Completed

Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia in Complete Remission

Leukemia

France
Institut Guttmann
Instituto de Salud Carlos III

Completed

Non-invasive Brain Stimulation for Gait Improvement in Patients With Spinal Cord Injury (SCI)

Functional Improvement
Institut Paoli-Calmettes

Unknown

Gemcitabine With or Without Sorafenib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Pancreatic Cancer

France
Institut Paoli-Calmettes

Completed

Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological Cancer

Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Neoplasms

France
Institut Paoli-Calmettes

Completed

Natural Killer Cells in Older Patients With Acute Myeloid Leukemia

Leukemia

France
Institut Paoli-Calmettes

Completed

Fludarabine, Busulfan, Antithymocyte Globulin, and Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma That Has Not Responded to Treatment

Multiple Myeloma and Plasma Cell Neoplasm

France
Institut Paoli-Calmettes

Completed

Laromustine, Daunorubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia

Leukemia

France

Clinical Trials Sponsored by aQua-Institut

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Germany

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations